英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
unbeheld查看　unbeheld　在百度字典中的解释百度英翻中〔查看〕
unbeheld查看　unbeheld　在Google字典中的解释Google英翻中〔查看〕
unbeheld查看　unbeheld　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • ESCC and GC GEJC Treatment | TEVIMBRA® (tislelizumab-jsgr)
    TEVIMBRA is a prescription medicine used to treat adults with: cancer of the tube that connects your throat to your stomach (esophageal cancer) TEVIMBRA may be used in combination with chemotherapy that contains platinum as your first treatment when your esophageal cancer: is a type called squamous cell carcinoma, and cannot be removed with surgery or has spread to other parts of the body
  • TEVIMBRA - accessdata. fda. gov
    1 2 Gastric Cancer TEVIMBRA, in combination with platinum and fluoropyrimidine-based chemotherapy, is indicated for the first-line treatment of adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G GEJ) whose tumors express PD-L1 (≥1)
  • Tevimbra: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Tevimbra is used to treat adults with certain types of esophageal squamous cell carcinoma (ESCC), gastric adenocarcinoma, or gastroesophageal junction adenocarcinoma that has spread (metastasized) or cannot be surgically removed
  • TEVIMBRA Approved in U. S. for First-line Treatment of Gastric . . .
    The additional indication for first-line G GEJ cancers is based on results from BeiGene’s RATIONALE-305 (NCT03777657), a randomized, double-blind, placebo-controlled, global Phase 3 trial to evaluate the efficacy and safety of TEVIMBRA in combination with chemotherapy as a first-line treatment for adult patients with advanced unresectable or metastatic G GEJ cancer The study met its primary
  • FDA Approves Tislelizumab Plus Chemo for PD-L1+ Unresectable . . .
    Key Takeaways Tislelizumab-jsgr (Tevimbra) approved for first-line treatment of HER2-negative gastric or GEJ adenocarcinoma with PD-L1 expression Phase 3 RATIONALE-305 trial showed significant
  • Review - accessdata. fda. gov
    1 2 Gastric Cancer TEVIMBRA, in combination with platinum and fluoropyrimidine-based chemotherapy, is indicated for the first-line treatment of adults with unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G GEJ) whose tumors express PD-L1 (≥1)
  • How it Works on ESCC | TEVIMBRA® (tislelizumab-jsgr)
    Flip the switch to see how TEVIMBRA works In the immune system of someone receiving TEVIMBRA treatment, T cells are “switched back on” to fight cancer TEVIMBRA attaches to T cells, keeping the “switch” on, so T cells can find and eliminate the cancer cells
  • FDA Approves Tislelizumab in Combination With Chemotherapy . . .
    The FDA approved tislelizumab-jsgr (Tevimbra; BeiGene Ltd) in combination with platinum and fluoropyrimidine-based chemotherapy as first line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma (G GEJ) for tumors that express programmed cell death ligand 1 (PD-L1) 1
  • Tevimbra Ziihera combination granted priority review to treat . . .
    The FDA has granted priority review for a supplemental biologics license application (sBLA) for Tevimbra (tislelizumab) in combination with Ziihera (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced metastatic HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma
  • TEVIMBRA Approved in U. S. for First-line Treatment of Gastric . . .
    Gastric (stomach) cancer is the fifth most common cancer worldwide and the fifth highest leading cause of cancer deaths 1 Nearly 1 million new patients were diagnosed with gastric cancer in 2022





中文字典-英文字典  2005-2009